Management of Shock in Children With SAM or Severe Underweight and Diarrhea
Launched by INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH, BANGLADESH · Feb 7, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial aims to find out the best way to treat severely malnourished children who are experiencing shock due to dehydration and diarrhea. Diarrhea is a major cause of death in young children, especially those with severe acute malnutrition (SAM). In this study, researchers will compare two different approaches: giving medications that help improve blood flow and pressure, or performing blood transfusions, for children who do not respond to standard fluid treatments recommended by the World Health Organization (WHO).
To be eligible for the trial, children aged 1 to 59 months with acute malnutrition and diarrhea can participate, including those with conditions like cerebral palsy or Down syndrome. Caregivers must provide consent for their child to take part. If a child is very sick or needs immediate emergency care, they won't be included. Families who join the study can expect to receive specialized care while helping researchers learn more about the best treatments for these vulnerable children.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Children of either sex with acute malnutrition and diarrhea
- • 2. Age: 1-59 months
- • 3. Children with cerebral palsy (CP) and/or developmental delay, Down Syndrome with or without heart diseases
- • 4. Fluid refractory shock
- • 5. Consent from the caregivers/parents
- Exclusion Criteria:
- • 1. Having a rare blood group (Rh negative blood groups provided that donor is not available)
- • 2. A child requiring cardio-pulmonary resuscitation during screening or having gasping respiration
About International Centre For Diarrhoeal Disease Research, Bangladesh
The International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDRB) is a renowned research organization dedicated to addressing pressing public health challenges, particularly in the fields of infectious diseases and nutrition. Established in 1960, ICDDRB combines rigorous scientific research with robust clinical trials to develop innovative solutions for diarrheal diseases and other related health issues affecting vulnerable populations. With a commitment to improving health outcomes through evidence-based interventions, ICDDRB collaborates with global health partners and utilizes its extensive expertise in epidemiology, microbiology, and clinical medicine to advance knowledge and enhance healthcare delivery in Bangladesh and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Dhaka, , Bangladesh
Patients applied
Trial Officials
Tahmeed Ahmed, PhD
Principal Investigator
International Centre for Diarrhoeal Disease Research, Bangladesh
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials